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Gualtar, 4710-057 Braga, PortugalAbstract. To facilitate optimal application of appropriate scaffold architectures for
clinical trials, there is a need to compare different scaffold modifications under
similar experimental conditions. In this study was assessed the effectiveness of
poly-e-caprolactone (PCL) scaffolds fabricated by fused deposition modelling
(FDM), with varying material modifications, for the purposes of bone tissue
engineering. The incorporation of hydroxyapatite (HA) in PCL scaffolds, as well as
precalcification through immersion in a simulated body fluid (SBF) to produce a
biomimetic apatite coating on the scaffolds, was assessed. A series of in vitro studies
spanning 3 weeks as well as in vivo studies utilizing a subcutaneous nude mouse
model were carried out. PCL and HA–PCL scaffolds demonstrated increasing tissue
growth extending throughout the implants, as well as superior mechanical strength
and mineralization, as evidenced by X-ray imaging after 14 weeks in vivo. No
significant difference was found between PCL and HA–PCL scaffolds.
Precalcification with SBF did not result in increased osteoconductivity and cell
proliferation as previously reported. Conversely, tensile forces exerted by tissue
sheets bridging adjacent struts of the PCL scaffold caused flaking of the apatite
coating that resulted in impaired cell attachment, growth and mineralization. The
results suggest that scaffolds fabricated by FDM may have load-bearing
applications.Key words: bone tissue engineering; fused
deposition modelling; polymer scaffolds; hydro-
xyapatite; precalcification.
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Available online 9 June 2006There is a need for an alternative to auto-
genous bone as graft material for the
reconstruction of cranio-facial and orbital
defects, or as filler material in orthopaedic
surgery and fracture fixation. Bone frac-tures and trauma-related injuries account
for more than 1.3 million surgical proce-
dures per year in the United States8, and
reconstructive surgery requiring bone
grafts is carried out every day in hospitalsns. Published by Elsevier Ltd. All rights reserved.
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Fig. 1. Scanning electron micrographs showing: (A) PCL scaffold with a lay-down pattern of
08/608/1208 fabricated by FDM; (B) HA–PCL scaffolds have a fine apatite coating, obvious at
high magnification (C). (D) Precalcification of PCL scaffolds with simulated body fluid
produces a coarse, prominent apatite layer, obvious at high magnification (E). Original
magnification: (A, B and D) 50 and (C and E) 750.worldwide. Bone tissue engineering pro-
mises such an alternative, and many
groups have developed strategies based
on seeding of cells onto 3-dimensional
biodegradable polymeric scaffolds. Fabri-
cation techniques that have been described
for these scaffolds are myriad and include
fused deposition modelling (FDM)6, sol-
vent casting/salt leaching13, emulsion
freeze-drying22, phase separation10, 3D
printing17 and gas foaming/salt leaching15,
to name just a few. Two major structural
classes of biodegradable polymer scaffold
made using these techniques are the
‘foams’ or those with a structure like a
porous sponge24, and scaffolds fabricated
by fused deposition modelling with a
reproducible internal architecture much
like that of a honeycomb6. Foams have
been described to have a structure much
like that of trabecular bone5, and were the
earliest polymer structures explored for
use in bone and cartilage tissue engineer-
ing. Many studies have demonstrated lim-
itations with this architecture in bone
tissue engineering, such as limited tissue
growth confined to the surface of the
foam2,7, as well as poor structural proper-
ties, in particular low strength and stiff-
ness4,23.
Scaffolds made of poly-e-caprolactone
(PCL) and fabricated by fused deposition
modelling have also been described26,
with a highly reproducible internal struc-
ture based on layer-by-layer deposition of
thermoplastic material (Fig. 1A). Such
scaffolds were designed to retain their
mechanical properties for 5–6 months
and then gradually degrade over a period
of 2 years26. With a fully interconnected
pore network, these scaffolds were shown
to support proliferation of cells throughout
the scaffold6,4, as well as retain their
mechanical properties after implantation
in rabbits20, pigs18 and mice19. This tissue
engineering strategy may have a load-
bearing application, such as in the recon-
struction of long-bone defects or of large
critical sized defects in the calvarium or
orbit.
There is a need for studies to compare
the effect of various material modifica-
tions under similar experimental condi-
tions before tissue engineering moves to
clinical trials. This is essential to ensure
that the optimal scaffold architecture for a
specific application is used in patients. In
this study, the effect of incorporation of
hydroxyapatite (HA) (Fig. 1B and C), as
well as precalcification in simulated body
fluid (SBF) (Fig. 1D and E), was compared
with untreated PCL FDM scaffolds for the
purposes of bone tissue engineering. The
growth of osteoblasts on these scaffoldswas evaluated in vitro and in a nude mouse
model, as well as comparing the degrada-
tion characteristics in vivo. A subcuta-
neous nude mouse model was ideal for
this experiment, due to the different envi-
sioned applications of these scaffolds in
the clinic.
Previous studies have shown that blends
of HA and polymers as composite scaf-
folds enhance osteoconductivity, as well
as improving mechanical properties, cell
survival and proliferation12,9. Improved
cell survival has been postulated to be
related to the maintenance of a neutral
pH, due to basic resorption by-products
of HA buffering acidic resorption by-pro-
ducts of aliphatic polyesters4. Surface
modification of polymer scaffolds by the
formation of a bone-like apatite layer
through immersion in SBF has also been
reported14,25, and MG63 cells were shown
to attach to Bioglass-filled polylactide
foams after immersion in SBF2. This form
of surface modification is used with the
same aim as composite scaffolds incorpor-
ating HA: to enhance osteoconductivity
and improve the mechanical properties of
the scaffold. To the authors’ knowledge,this is the first report of a direct compar-
ison between different material modifica-
tions in a similar experimental setting for
the purposes of bone tissue engineering.Materials and methods
Fabrication of scaffolds by fused
deposition modelling
PCL scaffolds were fabricated by FDM as
previously described by HUTMACHER et al.6
For HA–PCL scaffolds, PCL powder (cat-
alog no. 44, 074-4, Aldrich Chemical Co.,
Milwaukee, WI, USA), Mn of approxi-
mately 80,000 Da (gel permeation chromo-
graphy) and melt index of 1.0 g/10 min
(125 8C/44 psi ASTM D1238-73), and
HA (microemulsion-derived CaPO4 pow-
der) were dried separately for 24 h in a
vacuum oven at 120 and 40 8C, respec-
tively. Composite pellets of PCL–HAwere
then formed by casting a solventmixture of
20 g PCL–HA blend with 15% HA by
weight. The composite material was cut
into 5 mm  5 mm pellets and stored in a
desiccator until used. The PCL–HA pellets
were melt extruded to form monofilaments
930 Chim et al.using a one-shot extruder (Alex James &
Associates, Greenville, SC, USA). HA–
PCL scaffolds were then fabricated by
FDM as described. PCL and HA–PCL
scaffolds (PCL/HA = 85%/15%) with a
lay-downpattern of 0/60/120 and a porosity
of 65% were used. All scaffolds had a
dimension of 10 mm  10 mm  8 mm.
Prior to seeding they were sterilized by
centrifugation in 70% ethanol. Ethanol
was removed by washing 3 times for 1 h
each in changes of phosphate-buffered sal-
ine (PBS).Subsequently, the scaffoldswere
transferred into 24-well plates, and dried in
an incubator at 37 8C for 24 h.Biomimetic coating using a SBF
To produce the biomimetic coatings the
materials were submitted to a previously
developed procedure16. The PCL scaffolds
were ‘impregnated’ with a sodium silicate
gel. This treatment was aimed at generating
nucleating sites for the formation of the
apatite layers. After the treatment the sam-
ples were immersed in 50 ml of SBF (pH
7.4, 37 8C)with an ion concentration nearly
equal to that of human blood plasma (SBF
1). After 7 days, the ion concentration of
the SBF solution was raised to 1.5, to
induce growth of apatite nuclei. SBF solu-
tions were changed every 2 days. The coat-
ing period was 30 days in duration. After
coating, samples were rinsed in de-ionized
water and dried at room temperature.Cell isolation, seeding and culture
Human calvarial osteoblasts were isolated
via explant culture from a piece of calvar-
ium obtained from an infant undergoing
reconstructive surgery. Non-osseous tis-
sue was mechanically removed and the
specimen was manually broken up into
fragments measuring 5 mm  5 mm.
These fragments were extensively washed
in PBS and seeded into T-75 culture flasks.
The cells were cultivated in M199 med-
ium (GIBCO, Rockville, MD, USA) sup-
plemented with 10% foetal calf serum and
1% penicillin–streptomycin (GIBCO).
Osteogenic supplements (ascorbate dipho-
sphate, b-glycerophosphate) were added.
Medium was changed every 4 days.Cell growth and differentiation in vitro in
combination with scaffolds
After 2 weeks of explant culture in T-75
flasks, cells were detached with 0.25%
trypsin–EDTA, centrifuged, washed with
PBS, and seeded on polymer scaffolds.
Three different groups of scaffolds were
defined: (1) PCL FDM scaffolds, (2) HA–PCL FDM scaffolds and (3) PCL FDM
scaffolds treated with SBF. Cells were
seeded at a density of 1  105 cells on
scaffolds with dimensions of 10 mm 
10 mm  8 mm. The scaffolds were cul-
tivated in M199 medium as described, and
medium was changed every 3–4 days. To
facilitate osteogenic differentiation, cells
were stimulated with 10 mM dexametha-
sone on days 3 and 10 of culture. Cell–
scaffold constructs were maintained in 24-
well plates. At various time points, super-
natant was collected before fresh medium
was added, and stored at 80 8C. The
supernatant was subsequently analysed
for expression of alkaline phosphatase
(ALP) and osteocalcin. The cell–scaffold
constructs were serially observed under a
phase-contrast light microscope.
Confocal laser microscopy was also
used to assess cell morphology, prolifera-
tion and attachment in vitro. Samples were
first fixed in 3.7% formaldehyde at room
temperature for 30 min. After rinsing
twice with PBS for 5 min each, RNase
A (200 mg/mL) was added and the sam-
ples incubated at room temperature for
30 min. Phalloidin (A12379 Alexa Fluo
488 phalloidin; Molecular Probes,
Eugene, OR, USA) was then added at
1:200 dilution at room temperature and
the samples were kept in darkness for
45 min. Samples were then counterstained
with a 5 mg/mL concentration of propi-
dium iodide (1 mg/mL; Molecular Probes)
solution, dried and mounted for viewing
under a confocal laser microscope (IX70,
Olympus). Cell viability and distribution
within the scaffolds were assessed with the
fluorescent dye fluorescein diacetate
(Molecular Probes) and propidium iodide
as the counterstain. Depth projection
images were constructed from up to 50
horizontal image sections (20 mm each)
through the stained cell–scaffold con-
structs.Metabolic assays (in vitro)
To assess phenotype of osteoblasts seeded
on polymer scaffolds in vitro, ALP and
osteocalcin assays were performed. Super-
natant from different time points on days
1–20 of incubation was used. This was
stored at80 8C until assayed. For assess-
ment of ALP (n = 3), the production of p-
nitrophenol in the presence of ALP was
measured by a bone-specific immunoas-
say (Metra BAP EIA kit; Quidel, San
Diego, CA, USA). The concentration of
the major N-terminal fragment of osteo-
calcin (n = 1) was assayed by an enzyme-
linked immunoassay kit (Metra Osteocal-
cin; Quidel).Animal surgery
Cell–scaffold constructs were implanted
subcutaneously in the back of Balb C nude
mice (n = 3) after 21 days in culture. The 3
groups of constructs (1–3) described
above were implanted together in the back
of a single mouse. Animals tolerated sur-
gery well. The mice were killed after 6 and
14 weeks, and the specimen retrieved en-
bloc for histology, mechanical testing and
analysis of degradation of scaffolds. Hous-
ing and feeding of the animals was accord-
ing to standard animal care protocols. The
study was approved by the Animal Wel-
fare Committee, National University of
Singapore, and licensed by the National
Institute of Health’s guide for care and use
of laboratory animals.Mechanical testing and image analysis
Samples retrieved after 14 weeks in vivo
were compared to matched unseeded scaf-
folds of similar dimension and fabrication
for compression testing. Six different
points on each construct were tested on
an Instron 4502 uniaxial testing system
with a 10-N load cell (Canton, MA, USA)
using an indenter with a diameter of
0.625 mm. The specimens were firmly
secured onto a vise to ensure immobiliza-
tion and a flat testing surface. The com-
pression test was divided into 2 steps. In
the first loading phase, a load of up to 10 N
was applied at 0.1 mm/min. Results of this
phase were analysed and the stiffness
(loading between 8 and 10 N) of each
reconstructed area was calculated. The
second phase included a holding phase
at 10 N for 60 s, for deformation rate
measurements (creep). Afterwards the
indenter was unloaded at 2.5 mm/min.
The explanted en-bloc specimen consist-
ing of all 4 scaffolds implanted in the mice
was imaged with an X-ray scanning ana-
lytical microscope (XSAM) (XGT-2000;
Horiba, Tokyo, Japan).Statistical analysis
Results of metabolic assays reported are
means of at least 3 different samples of
supernatant. Differences in mean values of
ALP activity at different time points were
analysed by unpaired, 2-tailed t-tests; P
values less than 0.05 were considered
significant.Results
Cell growth and differentiation in vitro
Calvarial osteoblasts were successfully
isolated and seeded onto the 3 different
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Fig. 2. Phase-contrast light microscopy of scaffolds 11 days after seeding. (A) PCL and (B) HA–PCL scaffolds show a tissue sheet bridging
adjacent struts. (C) PCL scaffolds treated with SBF showing flaking of the induced apatite layer and subsequent detachment of cells from the
scaffold bars. Original magnification: (A–C) 100.groups of polymer scaffolds, after initial
expansion in 2-dimensional culture for 2
weeks. When seeded onto all 3 types of
scaffold, cells attached, spread and prolif-
erated, adopting a stellate morphology
typical of attached cells, with numerous
filopodia and cell-to-cell contacts visible.
The PCL FDM and HA–PCL FDM scaf-
folds demonstrated a constant rate of cell
proliferation, with cells initially attaching
to the scaffold bars and later forming
sheets of cells bridging adjacent scaffold
struts (Fig. 2A and B). Cells penetrated
deep into the centre of the PCL scaffolds,
where tissue sheets were even observed.
Confocal laser microscopy confirmed the
uniform distribution of cells throughout
the PCL (Fig. 3A) and HA–PCL
(Fig. 3B) scaffolds. Grossly, there was
no difference in cell morphology or pro-
liferation between the PCL and HA–PCL
cell–scaffold constructs.
The PCL scaffolds treated with SBF did
not support cell growth as well as the PCL
or HA–PCL scaffolds. In the initial phase,
cells attached to the bars of the coated PCLFig. 3. Confocal laser microscopy with depth pro
of cells within the scaffolds. (A) PCL and (B) HA
centre of the construct. (C) Few cells are seen on
contact, unlike cells on the other 3 scaffolds. Oscaffolds. It was observed subsequently
that, with formation of tissue sheets brid-
ging adjacent struts, sheets of cells
detached from the bars of the scaffolds
(Fig. 2C). Grossly, flaking of the apatite
layer was seen on the bars of the scaffolds.
This was probably a result of the apatite
layer being to thick, due to an overly
prolonged period of SBF immersion, such
that the structural integrity of the coating
on the PCL fibres was affected. Further
studies to determine the optimum time for
SBF immersion, so as to achieve a stable,
continuous adherent apatite layer are
required. Confocal laser microscopy
showed that while there were still cells
attached to the scaffold, these did not form
a confluent layer, and were at a lower
density than in the other 3 scaffold groups
(Fig. 3C).
Analysis of ALP and osteocalcin
expression by osteoblasts revealed a trend
consistent with that expected of calvarial
osteoblasts in culture for the PCL andHA–
PCL scaffolds. Previously, it was shown
that during culture of rat calvarial osteo-jection images reconstructed from multiple horiz
–PCL scaffolds show even distribution of cells alo
the PCL scaffolds treated with SBF, and these do
riginal magnification: (A–C) 50.blasts, expression of osteocalcin synthesis
occurred subsequent to initiation of ALP
activity and together with the formation of
mineralized nodules1. ALP has been
described as an early marker in osteogen-
esis, while osteocalcin is a late marker that
is produced synchronously with produc-
tion of extracellular matrix1,4. ALP pro-
duction peaked immediately after seeding
in all scaffolds (Fig. 4A), as measured on
day 1, falling to a trough and subsequently
reaching a peak again between days 17
and 20 after seeding. During the course of
the in vitro study, ALP production was
consistently lower for the SBF-treated
PCL scaffold than the PCL and HA–
PCL scaffolds, the difference increasing
substantially from day 10 after seeding
and reaching statistical significance on
days 17 and 20 (P < 0.05). The lack of
ALP expression for the apatite-coated
PCL is in concordance with that observed
by light and confocal laser microscopy,
and was probably due to an increasing
number of non-viable cells as the apatite
layer sloughed off the bars of the scaffold.ontal images shows 3-dimensional distribution
ng the bars of the scaffolds, extending into the
not form a confluent network with cell-to-cell
932 Chim et al.
Fig. 4. Metabolic assays were performed to assess expression of osteogenic markers during a
21-day period in vitro. (A) ALP expression peaked immediately after seeding in all scaffolds,
then slowly fell and peaked again between days 17 and 20 for the PCL and HA–PCL scaffolds.
From day 10 onwards, ALP expression for the SBF-treated PCL scaffolds was consistently
lower, reaching statistical significance on days 17 and 20 (P < 0.05). (B) Osteocalcin (OC)
expression peaked at day 10 for the PCL and HA–PCL scaffolds.Similarly, for osteocalcin expression
(Fig. 4B), while a peak was observed
for the PCL and HA–PCL scaffolds 10
days after seeding, no peak was visible for
the SBF-treated PCL scaffolds. Formation
of extracellular matrix was observed
throughout the PCL and HA–PCL scaffold
architecture, increasing gradually and fill-
ing the whole scaffold by 3 weeks (data
not shown), as previously demon-
strated4,21. Production of extracellular
matrix accompanied osteocalcin expres-
sion in these scaffolds. For the SBF-trea-
ted PCL scaffolds, the lack of osteocalcin
expression can be explained by an inabil-
ity of cells to attach properly to the scaf-
fold bars, and subsequently being unable
to secrete and produce extracellular
matrix.Fig. 5. Cell-seeded scaffolds were implanted subcutaneously in the back of Balb C nude mice
after 21 days in culture (A). Explantation of the implant 14 weeks later showed evidence of
vasculogenesis (B). In this specimen, 4 vessels can be seen emanating from the PCL construct,
and 1 from the HA–PCL construct. (C) An X-ray taken of the explanted specimen showed
evidence of mineralization (bright white areas) in PCL and HA–PCL scaffolds. This was less
pronounced in the SBF PCL scaffold.Comparative analysis of different
scaffolds in a nude mouse model
The different scaffolds loaded with cells
after a 3-week period of in vitro culture
were implanted simultaneously into the
back of Balb C nude mice (Fig. 5A).The implants were well integrated into
the surrounding tissue and there was no
evidence of encapsulation or excessive
fibrosis. Gross examination of the
explanted specimen 14 weeks after
implantation revealed evidence of vascu-
lar ingrowth, particularly pronounced for
the PCL and HA–PCL scaffolds. In the
representative specimen shown (Fig. 5B),
3 blood vessels can be seen emanating
from the PCL scaffold, and 1 from the
HA–PCL scaffold. Gross evidence of vas-
culogenesis was absent for the SBF-trea-
ted PCL and poly(DL-lactic-co-glycolic
acid) (PLGA) foams. Increased vasculo-
genesis in the PCL and HA–PCL scaffolds
would be expected, considering increased
cell proliferation and expression of osteo-
genic markers, as shown in the in vitro
study. An X-ray micrograph of the
explanted specimen (Fig. 5C) showed that
while mineralization (bright white areas)
was prominent in the PCL and HA–PCL
scaffolds, it was less pronounced in the
SBF-treated PCL scaffold and PLGA
foams. This is to be expected on the basis
of the findings of the in vitro study
described above.
Mechanical testing was performed to
assess the structural integrity of unseeded
control scaffolds and specimens explanted
after 14 weeks in a nude mouse model.
The mean stiffness (Fig. 6A) of the PCL,
HA–PCL and apatite-coated PCL was
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Fig. 6. Mechanical testing was performed on explanted scaffolds after 14 weeks in vivo with
matched control unseeded scaffolds. (A) Mean stiffness is similar for PCL scaffolds. Stiffness
increased after in vivo culture in the PCL and HA–PCL scaffolds, but decreased for the SBF PCL
scaffolds. (B) Maximum load that could be supported before indentation of the scaffolds was
greatest in the PCL and least in the SBF PCL scaffolds.similar, as would be expected in scaffolds
with the same architecture and composi-
tion, but the stiffness of the apatite-coated
PCL scaffold after 14 weeks implantation
was less than that of a control scaffold.
Conversely, the stiffness of the PCL and
HA–PCL specimens increased after the
period of in vivo implantation; this was
expected to occur due to ingrowth of tissue
and formation of extracellular matrix. The
decreased stiffness of the SBF-treated
PCL scaffolds after implantation could
be explained by poor attachment of cells
to the unstable apatite layer in vivo, and
therefore decreased mechanical strength.
The maximum load that could be sup-
ported before indentation of the scaffold
(Fig. 6B) was in the order of PCL, HA–
PCL, SBF-treated PCL; again, this was as
expected.Discussion
For tissue-engineering strategies to pro-
gress to clinic trials, adequate studies must
be performed to compare different scaf-
fold modifications and cells under similar
experimental conditions. Here, it wassought to compare different modifications
on a scaffold designed for load-bearing
applications in bone tissue engineering.
Scaffolds fabricated by FDM have ade-
quate mechanical strength, and allow
ingrowth of tissue throughout the implant,
as demonstrated. The fabrication process
allows customized shaped implants to be
generated from computed tomography
(CT) data6.
The effect was investigated of incor-
poration of HA into the scaffold mate-
rial, and precalcification with SBF to
produce a biomimetic apatite coating
in PCL scaffolds made by FBM. While
previous studies reported beneficial
effects of HA in composite scaffolds9,12,
a significant difference was not found
between PCL and HA–PCL scaffolds in
the present experiments. It is postulated
that, because of the fully interconnected
network and large porous spaces of the
FDM architecture, at baseline osteocon-
ductivity is already relatively high, and
therefore, HA incorporation did not
result in a significant increase. In addi-
tion, the enhanced cell proliferation and
mechanical properties attributed to HAincorporation were reported from experi-
ments conducted on ‘foams’, with
decreased cell penetration and poorer
mechanical properties compared to the
FDM scaffolds.
While precalcification with SBF pro-
mises similar benefits to incorporation of
HA into polymer scaffolds, it was found
that, conversely, this was detrimental in
the present experiments. Studies have
reported attachment of MG63 cells to
Bioglass-filled polylactide foams2, as
well as enhanced growth of human osteo-
blast-like cells on polymer–glass compo-
sites11 and glass fibres3 over 14 days in
culture. While these findings are dis-
puted, the 3-dimensional porous archi-
tecture of the PCL FDM scaffolds
dictates different mechanical constraints
on cells attaching and growing on the
bars of the scaffold. Cells seeded on
scaffolds such as those used in this study
will naturally form a tissue sheet brid-
ging adjacent bars, as was shown here
and previously4,6,20,21. The tensile force
exerted by this free tissue sheet on the
scaffold bars is greater than would be
expected for cells grown on foams or
fibres, which attach individually to the
supporting material. This would explain
the poor attachment of cells to the SBF-
treated PCL scaffold in vitro, and the
observed flaking of the apatite layer.
While precalcification with SBF might
be a viable form of surface treatment for
scaffolds of a ‘foam’ architecture or for
2-dimensional surfaces, the method as
currently described may not be suitable
for 3-dimensional scaffolds made by
FDM. A thinner apatite layer, achieved
through shorter immersion times in SBF
and lower SBF concentrations, may yield
more promising results.
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